Nihon Kohden Corporation (JP:6849) has released an update.
Nihon Kohden Corporation has announced the acquisition of a 71.4% stake in NeuroAdvanced Corp., a U.S.-based parent company of Ad-Tech Medical Instrument Corporation, with the intent to consolidate and enhance their neurology product lines and consumables portfolio. This strategic move aims to strengthen Nihon Kohden’s position in the neurology field, particularly in the area of epilepsy diagnosis and treatment, and is expected to contribute to a stable revenue base and potential growth. The agreement includes a shareholders agreement with a put option, enabling potential future full acquisition by Nihon Kohden, thus solidifying their commitment to providing comprehensive care solutions in neurology.
For further insights into JP:6849 stock, check out TipRanks’ Stock Analysis page.